Ractigen Therapeutics is a clinical stage biotech company committed to bringing to market first-in-class therapies designed to selectively restore the expression of therapeutic genes silenced in diseased cells. Its core technology is based on a paradigm-shifting discovery known as RNA activation (RNAa). Founded in 2016 by the pioneers in the field, Ractigen is developing a rich pipeline of candidate medicines for patients with unmet need.
Company Details
- Employees
- 21
- Founded
- 2017
- Address
- 金谷路99号, 苏州工业园区生物医药产业园三期 B 区 1 号楼四层,china
- Phone
- (+86) 513-81996959
- su****@****gen.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- ractigen.com
- HQ
- Suzhou, Jiangsu
Ractigen Therapeutics Questions
Ractigen Therapeutics's helpline number is (+86) 513-81996959
Ractigen Therapeutics's website is ractigen.com
Ractigen Therapeutics's LinkedIn profile is https://cn.linkedin.com/company/ractigen-therapeutics
Ractigen Therapeutics has
21 employees.
View email and phone details for 21
employees at Ractigen Therapeutics.
Ractigen Therapeutics's industry is
Pharmaceutical Manufacturing
Ractigen Therapeutics's top competitors are
Tiziana Life Sciences,
Uniqure,
Truebinding,
Neuron23,
Cerevance,
Voyager Therapeutics, Inc.,
Quralis,
Verge Genomics,
Sangamo Therapeutics, Inc.,
Externa.
Ractigen Therapeutics's support email address is support@ractigen.com
Ractigen Therapeutics's categories are Pharmaceutical Manufacturing
Ractigen Therapeutics's founding year is 2017
